Provided by Tiger Trade Technology Pte. Ltd.

Rocket Pharmaceuticals, Inc.

3.53
+0.02000.57%
Post-market: 3.52-0.0100-0.28%19:30 EDT
Volume:913.30K
Turnover:3.19M
Market Cap:387.50M
PE:-20.76
High:3.55
Open:3.53
Low:3.38
Close:3.51
52wk High:5.45
52wk Low:2.53
Shares:109.77M
Float Shares:84.96M
Volume Ratio:0.75
T/O Rate:1.07%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.1700
EPS(LYR):-2.0100
ROE:-4.77%
ROA:-28.42%
PB:1.05
PE(LYR):-1.76

Loading ...

Analysts Offer Insights on Healthcare Companies: Atara Biotherapeutics (ATRA), Artivion (AORT) and Rocket Pharmaceuticals (RCKT)

TIPRANKS
·
May 08

Rocket Pharmaceuticals Q1 EPS $(0.42) Beats $(0.43) Estimate

Benzinga Earnings
·
May 08

Rocket Pharma Q1 net loss narrows to $47.6 million; R&D expenses fall to $31.5 million

Reuters
·
May 08

Rocket Pharmaceuticals Inc expected to post a loss of 41 cents a share - Earnings Preview

Reuters
·
May 04

Analysts Offer Insights on Healthcare Companies: Rocket Pharmaceuticals (RCKT) and TriSalus Life Sciences (TLSI)

TIPRANKS
·
Apr 29

Rocket Pharmaceuticals Inc : Leerink Partners Raises Target Price to $12 From $11

THOMSON REUTERS
·
Apr 28

Rocket Pharma sells priority review voucher for $180 million

Reuters
·
Apr 28

Rocket Pharmaceuticals Announces $180 Million Sale of Priority Review Voucher

THOMSON REUTERS
·
Apr 28

Rocket Pharmaceuticals Inc - Cash Runway Extended Into Second Quarter of 2028

THOMSON REUTERS
·
Apr 28

LifeSci Capital Sticks to Their Buy Rating for Rocket Pharmaceuticals (RCKT)

TIPRANKS
·
Apr 20

Rocket Pharma Advances Cardiac Gene Therapy Trial, Keeping RCKT on Investors’ Radar

TIPRANKS
·
Apr 17

US FDA's accelerated approval for drugs needs more transparency, says research firm

Reuters
·
Apr 16

Analysts Conflicted on These Healthcare Names: Rocket Pharmaceuticals (RCKT), Merit Medical Systems (MMSI) and Vaxcyte (PCVX)

TIPRANKS
·
Apr 15

Analysts’ Opinions Are Mixed on These Healthcare Stocks: Rocket Pharmaceuticals (RCKT) and Moderna (MRNA)

TIPRANKS
·
Apr 06

BRIEF-FDA Issuance Of A Priority Review Voucher To The Sponsor Of A Rare Pediatric Disease Product Application- Federal Register Website

Reuters
·
Apr 01

FDA: Issuance of a Priority Review Voucher to the Sponsor of a Rare Pediatric Disease Product Application- Federal Register Website

THOMSON REUTERS
·
Apr 01

Rocket Pharmaceuticals Is Maintained at Buy by B of A Securities

Dow Jones
·
Mar 30

Assessing Rocket Pharmaceuticals (RCKT) Valuation After Accelerated FDA Approval Of KRESLADI

Simply Wall St.
·
Mar 30

Rocket Pharmaceuticals price target raised to $11 from $9 at Leerink

TIPRANKS
·
Mar 28

Rocket Pharmaceuticals Is Maintained at Buy by Chardan Capital

Dow Jones
·
Mar 28